19-40717864-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000263370.3(ITPKC):c.729G>T(p.Glu243Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,613,996 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000263370.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPKC | NM_025194.3 | c.729G>T | p.Glu243Asp | missense_variant | 1/7 | ENST00000263370.3 | NP_079470.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPKC | ENST00000263370.3 | c.729G>T | p.Glu243Asp | missense_variant | 1/7 | 1 | NM_025194.3 | ENSP00000263370 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000362 AC: 91AN: 251386Hom.: 1 AF XY: 0.000353 AC XY: 48AN XY: 135898
GnomAD4 exome AF: 0.000214 AC: 313AN: 1461876Hom.: 1 Cov.: 32 AF XY: 0.000220 AC XY: 160AN XY: 727240
GnomAD4 genome AF: 0.000250 AC: 38AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.729G>T (p.E243D) alteration is located in exon 1 (coding exon 1) of the ITPKC gene. This alteration results from a G to T substitution at nucleotide position 729, causing the glutamic acid (E) at amino acid position 243 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at